Immunogenicity 9553

summary
Sample ID
3812
Response
Negative
Tumor Type
Bile duct cancer
Gene Symbol
TPSB2
Transcript ID
ENST00000430512
HLA INFO
A*68:01
TCR INFO

No TCR info found!

T cell Tumor cell A*68:01
sequence
Full length protein sequence (274 aa)
MLNLL
1
LLALP
6
VLASR
11
AYAAP
16
APGQA
21
LQRVG
26
IVGGQ
31
EAPRS
36
KWPWQ
41
VSLRV
46
RDRYW
51
MHFCG
56
GSLIH
61
PQWVL
66
TAAHC
71
VGPDV
76
KDLAA
81
LRVQL
86
REQHL
91
YYQDQ
96
LLPVS
101
RIIVH
106
PQFYT
111
AQIGA
116
DIALL
121
ELEEP
126
VNVSS
131
HVHTV
136
TLPPA
141
SETFP
146
PMPCW
151
VTGWG
156
DVDND
161
ERLPP
166
PFPLK
171
QVKVP
176
IMENH
181
ICDAK
186
YHLGA
191
YTGDD
196
VRIVR
201
DDMLC
206
AGNTR
211
RDSCQ
216
GDSGG
221
PLVCK
226
VNGTW
231
LQAGV
236
VSWGE
241
GCAQP
246
NRPGI
251
YTRVT
256
YYLDW
261
IHHYV
266
PKKP
271
Mutation Information
DNA mutation:
None
Peptide Range:
91 ~ 115
Mut AA position:
103 (13 in Wild Type peptide)
Alignment
Wild Type:
"REQHLYYQDQLLPVSRIIVHPQFYT
||||||||||||.||||||||||||
Mutant:
REQHLYYQDQLLLVSRIIVHPQFYT"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) TPSB2

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

None

Assay

IFNg ELISPOT assay